GenMont Biotech Stock

GenMont Biotech EBIT

The EBIT of GenMont Biotech (3164.TW) as of Aug 20, 2026 is 57.75 M TWD. In the previous year, EBIT was 40.12 M TWD — a change of 43.95% (higher).

EBIT

57.75 MTWD

YoY

43.95%

Last updated:

In 2026, GenMont Biotech's EBIT was 57.75 M TWD, a 43.95% increase from the 40.12 M TWD EBIT recorded in the previous year.

The GenMont Biotech EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M TWD)
Date
EBIT (M TWD)
Jan 1, 2018
122.82 base
Jan 1, 2019
76.77 base
Jan 1, 2020
77.00 base
Jan 1, 2021
143.49 base
Jan 1, 2022
60.18 base
Jan 1, 2023
6.99 base
Jan 1, 2024
40.12 base
Jan 1, 2025
57.75 base
YEAREBIT (M TWD)
2025 57.75
2024 40.12
2023 6.99
2022 60.18
2021 143.49
2020 77.00
2019 76.77
2018 122.82
2017 109.06
2016 -18.11
2015 -45.97
2014 -144.36
2013 56.90
2012 -29.49
2011 -16.63
2010 156.69
2009 96.27
2008 75.25
2007 67.26
2006 34.92
Access this data via the Eulerpool API

GenMont Biotech Revenue

GenMont Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
406.53 M TWD
122.82 M TWD
158.02 M TWD
Jan 1, 2019
346.24 M TWD
76.77 M TWD
57.45 M TWD
Jan 1, 2020
325.19 M TWD
77.00 M TWD
60.88 M TWD
Jan 1, 2021
427.93 M TWD
143.49 M TWD
113.13 M TWD
Jan 1, 2022
368.55 M TWD
60.18 M TWD
56.98 M TWD
Jan 1, 2023
318.02 M TWD
6.99 M TWD
32.99 M TWD
Jan 1, 2024
385.37 M TWD
40.12 M TWD
57.25 M TWD
Jan 1, 2025
401.23 M TWD
57.75 M TWD
57.20 M TWD

GenMont Biotech Margins

GenMont Biotech stock margins

The GenMont Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of GenMont Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for GenMont Biotech.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
68.27 %
30.21 %
38.87 %
Jan 1, 2019
66.34 %
22.17 %
16.59 %
Jan 1, 2020
66.23 %
23.68 %
18.72 %
Jan 1, 2021
69.95 %
33.53 %
26.44 %
Jan 1, 2022
69.66 %
16.33 %
15.46 %
Jan 1, 2023
66.41 %
2.20 %
10.37 %
Jan 1, 2024
61.80 %
10.41 %
14.86 %
Jan 1, 2025
62.72 %
14.39 %
14.26 %

GenMont Biotech Stock analysis

What does GenMont Biotech do? GenMont Biotech is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing GenMont Biotech's EBIT

GenMont Biotech's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of GenMont Biotech's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

GenMont Biotech's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in GenMont Biotech’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about GenMont Biotech stock

EBIT of GenMont Biotech is 57.75 M TWD in 2026.

EBIT of GenMont Biotech changed from 40.12 M TWD to 57.75 M TWD, representing a 43.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT GenMont Biotech since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's GenMont Biotech historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — GenMont Biotech

All Key Metrics — GenMont Biotech